Lisa Thompson advises companies, senior management, and their boards of directors, with a focus on the health care, life sciences and technology industries. She is a member of the firm’s Health Law Group and Data Privacy + Cybersecurity Team. She is also an arbitrator on the Commercial panel and the Health Care panel of the American Arbitration Association.
Health Care, Life Science and Technology Industries
Lisa represents domestic and international clients in the health care, life science and technology industries, including pharmaceutical companies, medical device manufacturers, biotechnology companies, hospital systems, academic medical centers, health information exchanges (HIEs) and technology services providers. In addition, she has represented third party administrators, pharmacy benefit managers, health plans, laboratories, physician practices, pharmacies and retail pharmacy chains, among others in these industries.
Lisa handles a range of matters, including corporate law and contracting, government investigations and audits, clinical research law, and matters involving Institutional Review Boards (IRBs). She has extensive experience representing clients on matters involving privacy and security including HIPAA, reimbursement, Medicare and Medicaid, state and federal surveys and termination actions, managed care disputes, pharmacy and compounding laws, fraud and abuse, Stark Law, anti-kickback, and federal program exclusions.
Lisa’s life sciences experience includes U.S. Food and Drug Administration (FDA) compliance and regulatory matters, product recalls and liability claims, FDA citizen petitions and appeals, labeling review, advertising and marketing compliance, drug and medical device reimbursement, clinical research agreements, Sunshine Act compliance, and commercial contracting. Her technology sector experience includes advising on privacy and security, software licensing, data use agreements, information exchange system agreements, and regulatory requirements.
She formerly served in-house as chief counsel for an international medical device manufacturer, as general counsel for a pharmacy benefit management company, and as corporate, privacy, and research counsel for a major academic medical center. She is a co-editor and contributor for the firm’s blog, Health Law Diagnosis.
More Legal and Business Bylines From Melissa (Lisa) Thompson
- CMS Issues Phase-In Recommendations for Non-COVID Non-Emergent Care - (Posted On Monday, April 20, 2020)
- New Massachusetts Law Provides Liability Protections for Health Care Professionals, Health Care Facilities and Volunteer Organizations During COVID-19 Emergency - (Posted On Saturday, April 18, 2020)
- CMS Updates Blanket Waivers to Help Expand Health Care Workforce - (Posted On Friday, April 10, 2020)
- Massachusetts Issues Further COVID-19 Updates for Providers - (Posted On Tuesday, March 31, 2020)
- Rhode Island Issues Emergency Regulations on Off-Label Prescribing for COVID-19, and Guidance on Telehealth and Reciprocal Licensure - (Posted On Wednesday, March 25, 2020)
- OHS Streamlines Application Process for CON Waivers to Respond to COVID-19 - (Posted On Wednesday, March 25, 2020)
- CMS Announces Targeted Plan for Healthcare Facility Inspections in Light of COVID-19 - (Posted On Tuesday, March 24, 2020)
- Massachusetts COVID-19 Updates and Guidance Issued - (Posted On Monday, March 23, 2020)
- COVID-19: HHS Issues FAQs on HIPAA and Telehealth to Help Providers Maintain Access to Care During the Pandemic - (Posted On Monday, March 23, 2020)
- Government Significantly Expands Telehealth Reimbursement During COVID-19 Public Health Emergency - (Posted On Tuesday, March 17, 2020)